Senior insider sale
PRESIDENT & CFO at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$1.55M
38.69K shares
What this filing means
MORTIMER IAN plans to sell 38.69K shares of XENON PHARMACEUTICALS INC. valued at approximately $1.55M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/24/2025ACC: 0000950170-25-008888
Officer· PRESIDENT & CFO
Since Sep 2019
38.69K
Shares to sell
$1.55M
Approx. market value
22.47K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Options
Cash
1/24/2025
22.47KTotal acquired22.47K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/24/2025 | Exercise of Options Cash | 22.47K | — |
| Total | 22.47K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
16.22K
Market value
$649.9K
1/23/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
22.47K
Market value
$903.3K
1/24/2025
Total
Units
38.69K
Value
$1.55M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/23/2025 | 16.22K | $649.9K | — | Completed |
| Planned — Approximate Date | ||||
1/24/2025 | 22.47K | $903.3K | NASDAQ | Planned |
| Total | 38.69K | $1.55M | ||